BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25413011)

  • 1. A close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institution.
    Peker D; Padron E; Bennett JM; Zhang X; Horna P; Epling-Burnette PK; Lancet JE; Pinilla-Ibarz J; Moscinski L; List AF; Komrokji RS; Zhang L
    Acta Haematol; 2015; 133(2):249-56. PubMed ID: 25413011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Fraison JB; Mekinian A; Grignano E; Kahn JE; Arlet JB; Decaux O; Denis G; Buchdahl AL; Omouri M; Maigne G; Aouba A; Leon N; Berthier S; Liozon E; Park S; Gardin C; Lortholary O; Rossignol J; Fenaux P; Fain O; Braun T
    Leuk Res; 2016 Apr; 43():13-7. PubMed ID: 26922775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands.
    Dinmohamed AG; van Norden Y; Visser O; Posthuma EF; Huijgens PC; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M
    Leuk Res; 2015 Feb; 39(2):177-82. PubMed ID: 25533930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune thrombocytopenia in chronic myelomonocytic leukemia.
    Hadjadj J; Michel M; Chauveheid MP; Godeau B; Papo T; Sacre K
    Eur J Haematol; 2014 Dec; 93(6):521-6. PubMed ID: 24913055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myelomonocytic leukemia: myelodysplastic or myeloproliferative?
    Itzykson R; Fenaux P; Solary E
    Best Pract Res Clin Haematol; 2013 Dec; 26(4):387-400. PubMed ID: 24507815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic progenitor cell colony growth differentiates chronic myelomonocytic leukemia from reactive monocytosis.
    Birrer A; Jusufi F; Bernimoulin M; Tichelli A; Gratwohl A; Nissen-Druey C; Dirnhofer S; Meyer-Monard S; Stern M
    Eur J Haematol; 2008 Oct; 81(4):267-72. PubMed ID: 18616511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of acquisition of cytogenetic abnormalities during the course of chronic myelomonocytic leukemia.
    Tang G; Fu B; Hu S; Lu X; Tang Z; Li S; Jabbar K; Khoury JD; Medeiros LJ; Wang SA
    Am J Hematol; 2015 Oct; 90(10):882-7. PubMed ID: 26148174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: a report of 12 patients].
    Sun YQ; Xu LP; Liu DH; Zhang XH; Han W; Chen H; Wang FR; Wang JZ; Wang Y; Chen YH; Liu KY; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):113-6. PubMed ID: 23611216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes.
    Montoro J; Gallur L; Merchán B; Molero A; Roldán E; Martínez-Valle F; Villacampa G; Navarrete M; Ortega M; Castellví J; Saumell S; Bobillo S; Bosch F; Valcárcel D
    Ann Hematol; 2018 Aug; 97(8):1349-1356. PubMed ID: 29572561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease in chronic myelomonocytic leukemia: do monocytosis and chronic inflammation predispose to accelerated atherosclerosis?
    Elbæk MV; Sørensen AL; Hasselbalch HC
    Ann Hematol; 2019 Jan; 98(1):101-109. PubMed ID: 30182347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
    Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
    Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?
    Melo JV; Myint H; Galton DA; Goldman JM
    Leukemia; 1994 Jan; 8(1):208-11. PubMed ID: 8289491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management.
    Parikh SA; Tefferi A
    Am J Hematol; 2012 Jun; 87(6):610-9. PubMed ID: 22615103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
    Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai JL; Cosson A; Fenaux P; Preudhomme C
    Haematologica; 1999 Dec; 84(12):1075-80. PubMed ID: 10586207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia.
    Cilloni D; Carturan S; Bracco E; Campia V; Rosso V; Torti D; Calabrese C; Gaidano V; Niparuck P; Favole A; Signorino E; Iacobucci I; Morano A; De Luca L; Musto P; Frassoni F; Saglio G
    Leuk Res; 2013 May; 37(5):520-30. PubMed ID: 23415111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
    Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
    Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic myelomonocytic leukemia: myeloproliferative variant.
    Onida F; Beran M
    Curr Hematol Rep; 2004 May; 3(3):218-26. PubMed ID: 15087071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelodysplastic syndrome (MDS)-associated cytogenetic abnormalities in pediatric chronic myelogenous leukemia.
    Kumar KR; Koduru P; Timmons C; Monaghan S; Cavalier M; Luu HS
    Pediatr Blood Cancer; 2013 Nov; 60(11):E146-8. PubMed ID: 23868765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias.
    Schuler E; Schroeder M; Neukirchen J; Strupp C; Xicoy B; Kündgen A; Hildebrandt B; Haas R; Gattermann N; Germing U
    Leuk Res; 2014 Dec; 38(12):1413-9. PubMed ID: 25444076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune disorders in patients with idiopathic thrombotic thrombocytopenic purpura.
    John ML; Scharrer I
    Hamostaseologie; 2012; 32 Suppl 1():S86-9. PubMed ID: 22960981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.